查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1986797

慢性阻塞性肺病和氣喘治療設備市場報告：按產品、適應症、通路和地區分類（2026-2034 年）

COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球慢性阻塞性肺病和氣喘治療設備市場規模達499億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到725億美元，2026年至2034年的複合年成長率（CAGR）為4.24%。市場成長的主要促進因素包括：具備即時監測功能的智慧吸入器技術的持續進步；呼吸系統疾病盛行率的上升；人們對更精準給藥的個人化治療日益關注；以及新興市場由於醫療保健服務改善而帶來的需求成長。

慢性阻塞性肺病（COPD）是一種發炎性疾病，會導致肺部氣流受阻。其初期症狀包括呼吸困難、喘息、胸悶、慢性咳嗽（伴隨或不伴隨痰）、頻繁感冒和咽喉痛。氣喘，也稱為支氣管氣喘，是一種影響肺部氣道的呼吸系統疾病。其症狀包括呼吸困難、胸悶、睡眠障礙、咳嗽和喘息發作。這些呼吸系統疾病的治療方法是使用各種輔助吸入藥物的裝置。 COPD和氣喘裝置（也稱為肺部藥物輸送裝置）既可用於呼吸系統疾病的常規治療，也可用於緊急治療。因此，它們已引起全球的廣泛關注。

慢性阻塞性肺病和氣喘治療設備的市場趨勢：

人們越來越關注個人化醫療

隨著製造商致力於提供針對每位患者個別需求的客製化解決方案，個人化醫療的興起正對慢性阻塞性肺病（COPD）和氣喘設備的市場佔有率產生顯著影響。旨在提升患者舒適度和治療精準度的可自訂吸入器和霧化器正日益受到關注。個人化給藥系統可確保藥物精準輸送，最大限度地減少副作用，並提高整體治療效果。此外，針對呼吸系統疾病特定分子路徑的生物製藥的興起，也推動了專用先進給藥設備的應用。這種個人化方法能夠更有效地管理慢性呼吸系統疾病。隨著對這些客製化解決方案的需求不斷成長，市場預計將持續擴張，這反映了呼吸系統治療領域中個人化醫療的更廣泛趨勢。

吸入器設計方面的技術進步

根據慢性阻塞性肺病（COPD）和氣喘治療設備市場的最新趨勢，吸入器技術的持續創新正在推動市場發展，並改變這些呼吸系統疾病的治療方式。配備感測器和藍牙連接功能的智慧吸入器能夠即時監測藥物使用和依從性。這項進步使患者和醫護人員能夠追蹤吸入模式並調整治療方案，從而改善疾病管理。行動應用程式的整合進一步增強了這一優勢，這些應用程式提供提醒功能、症狀追蹤功能以及與臨床醫生共用數據的功能。隨著數位健康解決方案的日益普及，對智慧吸入器的需求不斷成長，從而推動了整個COPD和氣喘設備市場的成長。

新興市場需求不斷成長

受新興經濟體需求的推動，慢性阻塞性肺病（COPD）和氣喘治療設備的市場規模正經歷強勁成長。快速的都市化、日益嚴重的空氣污染以及不斷上升的吸煙率等因素，導致亞太、拉丁美洲和中東等地區呼吸系統疾病的盛行率不斷上升。全球約有11億15歲以上的吸菸者，其中80%居住在中低收入國家（LMIC）。吸菸率的上升，尤其是在青少年群體中，除非實施更嚴格的監管，否則將加重健康和經濟負擔。這些地區的政府和醫療衛生系統正在投資研發更好的診斷工具和治療設備，以應對日益嚴重的COPD和氣喘負擔。此外，醫療服務可近性的提高以及攜帶式吸入器和霧化器的普及，也推動了這些地區的市場成長，使新興市場成為未來擴張的關鍵樞紐。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球慢性阻塞性肺病和氣喘治療設備市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 吸入器
    • 主要部分
      • 藥物粉末吸入器（DPI）
      • 定量噴霧吸入器（MDI）
      • 緩霧吸入器
  • 噴霧器
    • 主要部分
      • 壓縮式霧化器
      • 超音波霧化器
      • 篩孔式噴霧器

第7章 市場區隔：依應用領域分類

  • 氣喘
  • COPD

第8章 市場區隔：依分銷通路分類

  • 零售藥房
  • 醫院
  • 網路藥房

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Adherium Limited
    • Aerogen Ltd
    • AptarGroup, Inc.
    • Boehringer Ingelheim Pharmaceuticals, Inc.
    • Cipla Limited
    • GF Health Products, Inc
    • GSK plc
    • PARI Respiratory Equipment, Inc.
    • ResMed
    • Teva Pharmaceuticals USA, Inc.
Product Code: SR112026A6126

The global COPD and asthma devices market size reached USD 49.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 72.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.24% during 2026-2034. The market growth is primarily driven by continual technological advancements in smart inhalers with real-time monitoring capabilities, growing prevalence of respiratory conditions, an enhanced emphasis on personalized treatment options for more accurate drug delivery and increasing demand in emerging markets due to improved healthcare access.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD AND ASTHMA DEVICES MARKET TRENDS:

Increased Focus on Personalized Treatment Options

The shift towards personalized medicine is causing a substantial effect on the COPD and asthma devices market share, as manufacturers focus on offering solutions tailored to individual patient requirements. Customizable inhalers and nebulizers are becoming more prominent, designed to enhance patient comfort and treatment precision. Personalized dosing systems ensure accurate medication delivery, minimizing side effects and augmenting overall treatment effectiveness. Additionally, the rise of biologic therapies targeting specific molecular pathways involved in respiratory conditions, is encouraging the use of specialized and advanced delivery devices. This personalized approach allows for more effective management of chronic respiratory diseases. As demand for these customized solutions grows, the market is expected to expand, reflecting a broader trend towards individualized healthcare in respiratory treatment.

Technological Advancements in Inhaler Design

Ongoing innovations in inhaler technology are leading the market according to the latest COPD and asthma devices market trends, transforming the management of these respiratory conditions. Smart inhalers, equipped with sensors and Bluetooth connectivity, enable real-time monitoring of medication usage and adherence. This advancement allows patients and healthcare providers to track inhalation patterns and adjust treatments for improved disease control. The integration of mobile apps further supports this by offering reminders, symptom tracking, and data sharing with clinicians. As digital health solutions gain wider adoption, the demand for smart inhalers is rising, which is contributing to the overall growth of the COPD and asthma devices market.

Rising Demand in Emerging Markets

The COPD and asthma devices market size is witnessing strong growth in demand from emerging economies. Factors such as rapid urbanization, rising air pollution levels, and higher smoking rates are contributing to the prevalence of respiratory conditions in regions such as Asia-Pacific, Latin America, and the Middle East. Around 1.1 billion individuals over the age of 15 and over smoke, with 80% residing in low and middle income countries (LMICs). Rising smoking rates, especially among adolescents, pose growing health and economic burdens without stricter controls. Governments and healthcare systems in these regions are investing in better diagnostic tools and treatment devices to address the growing burden of COPD and asthma. Additionally, improved access to healthcare and the increasing adoption of portable inhalers and nebulizers are augmenting market growth in these regions, making emerging markets key centres for future expansion.

COPD AND ASTHMA DEVICES MARKET SEGMENTATION:

Breakup by Product:

  • Inhalers
    • Drug Powdered Inhalers (DPIs)
    • Metered Dose Inhalers (MDIs)
    • Soft Mist Inhalers
  • Nebulizers
    • Compressor Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

Breakup by Indication:

  • Asthma
  • COPD

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospitals
  • Online Pharmacies

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global COPD and asthma devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Adherium Limited
  • Aerogen Ltd
  • AptarGroup, Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Cipla Limited
  • GF Health Products, Inc
  • GSK plc
  • PARI Respiratory Equipment, Inc.
  • ResMed
  • Teva Pharmaceuticals USA, Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global COPD and asthma devices market in 2025?

2. What is the expected growth rate of the global COPD and asthma devices market during 2026-2034?

3. What are the key factors driving the global COPD and asthma devices market?

4. What has been the impact of COVID-19 on the global COPD and asthma devices market?

5. What is the breakup of the global COPD and asthma devices market based on the product?

6. What is the breakup of the global COPD and asthma devices market based on the indication?

7. What is the breakup of the global COPD and asthma devices market based on distribution channel?

8. What are the key regions in the global COPD and asthma devices market?

9. Who are the key players/companies in the global COPD and asthma devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Drug Powdered Inhalers (DPIs)
      • 6.1.2.2 Metered Dose Inhalers (MDIs)
      • 6.1.2.3 Soft Mist Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Compressor Nebulizers
      • 6.2.2.2 Ultrasonic Nebulizers
      • 6.2.2.3 Mesh Nebulizers
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 COPD
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aerogen Ltd
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AptarGroup, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Boehringer Ingelheim Pharmaceuticals, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Cipla Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GF Health Products, Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 GSK plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 PARI Respiratory Equipment, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 ResMed
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceuticals USA, Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
  • Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2025
  • Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2025
  • Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2025
  • Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2025
  • Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
  • Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
  • Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
  • Table 7: Global: COPD and Asthma Devices Market: Key Players